Regression Rate of Basal Cell Carcinoma in a Veteran Population: A Study of 317 Cases at the Kansas City Veterans Affairs Medical Center.
Year: 2025
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: This study aims to assess the regression rate of basal cell carcinoma (BCC) in excision specimens following diagnostic biopsies obtained from patients in a veterans affairs facility. METHODS: A retrospective review of biopsy-proven BCC excision cases was conducted. All included biopsy and corresponding excision reports were reviewed to determine the margin status of specimens. Proportion of residual carcinoma cases and regression rate of the tumor were determined. RESULTS: <0.01). The time interval between the biopsy and excision and age were not significantly different between regressed and non-regressed tumors. Neither of sexes and neither of tumor subtypes had significantly different regression rates as compared to the general study population. LIMITATIONS: The limitation of our study is that the data may not be generalizable due to our unique study population. CONCLUSION: BCC is a tumor with the potential to regress. However, definitive management resides in complete surgical excision, which will most likely remain the mainstay of treatment in the near future.
Source: PubMed
Authors: Margaryta Stoieva, Daniel Mettman
Institution: University of Kansas
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4417525000
FWCI:
Cites:
Cited by:
Related to: